ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

TERN Terns Pharmaceuticals Inc

5,23
-0,06 (-1,13%)
Zuletzt aktualisiert: 19:45:05
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Terns Pharmaceuticals Inc TERN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,06 -1,13% 5,23 19:45:05
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,39 5,22 5,57 5,29
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202422:05GLOBETerns Pharmaceuticals Announces Data from Ongoing Phase 1..
10.4.202422:05GLOBETerns Pharmaceuticals Appoints Melita Sun Jung as Chief..
14.3.202421:05GLOBETerns Pharmaceuticals Reports Fourth Quarter and Full Year..
11.3.202421:05GLOBETerns Pharmaceuticals Announces Orphan Drug Designation..
07.3.202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
06.3.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:05GLOBETerns Pharmaceuticals to Participate in Upcoming March..
16.2.202400:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.2.202414:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202422:20EDGAR2Form 8-K - Current report
07.2.202422:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New Chief..
07.2.202414:05GLOBETerns Pharmaceuticals Appoints Amy Burroughs as Chief..
02.2.202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
26.1.202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:05GLOBETerns Pharmaceuticals to Highlight 2024 Priorities and..
03.1.202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
29.11.202322:05GLOBETerns Pharmaceuticals to Present at the JMP Securities..
27.11.202322:05GLOBETerns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
14.11.202314:05GLOBETerns Pharmaceuticals Reports Third Quarter 2023 Financial..
13.11.202314:05GLOBETerns Pharmaceuticals Presents Late-Breaking Data from Phase..
09.11.202314:05GLOBETerns Pharmaceuticals to Participate in Upcoming November..
03.11.202321:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
02.11.202321:05GLOBETerns Pharmaceuticals Announces First Participant Dosed in..
19.10.202322:05GLOBETerns Pharmaceuticals to Participate in Upcoming Investor..
16.10.202314:05GLOBETerns Pharmaceuticals Announces Global Phase 1 Clinical..
10.10.202322:33EDGAR2Form 8-K - Current report
03.10.202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
06.9.202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
05.9.202322:05GLOBETerns Pharmaceuticals to Participate in Upcoming September..
08.8.202322:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:24EDGAR2Form 8-K - Current report
08.8.202322:15GLOBETerns Pharmaceuticals Reports Second Quarter 2023 Financial..
08.8.202322:05GLOBETerns Achieves Primary Endpoint and All Secondary Endpoints..
04.8.202300:00GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
03.8.202323:22EDGAR2Form 8-K - Current report
03.8.202323:05GLOBETerns Pharmaceuticals Announces Leadership Transition
18.7.202322:05GLOBETerns Pharmaceuticals to Host Virtual Key Opinion Leader..
05.7.202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
26.6.202322:05GLOBETerns Pharmaceuticals Highlights New Preclinical Data for..
06.6.202322:30GLOBETerns Pharmaceuticals to Present at Goldman Sachs 44th..
02.6.202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
25.5.202323:05GLOBETerns Pharmaceuticals Announces Publication of TERN-701..
24.5.202322:05GLOBETerns Pharmaceuticals to Present at Upcoming Investor..
22.5.202322:05GLOBETerns Pharmaceuticals to Highlight New Preclinical Data for..
15.5.202314:05GLOBETerns Pharmaceuticals Reports First Quarter 2023 Financial..
09.5.202322:05GLOBETerns Pharmaceuticals to Participate in the JMP Securities..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock